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Adjuvant  radiotherapy  after  surgery  or exclusive  radiotherapy,  with  or without  concurrent  chemotherapyadiotherapy
oxicities
is a valuable  treatment  option  in the  great  majority  of  patients  with  head  and neck  cancer.  Recent  technical
progress  in  radiotherapy  has resulted  in a  decreased  incidence  of  xerostomia.  Another  common  toxicity
of radiotherapy  is  dysphagia,  which  alters  the nutritional  status  and  quality  of  life  of  patients  in  remission.
The  objective  of this  review  is  to describe  the  physiology  of  swallowing  function,  the  pathophysiology  of
radiation-induced  dysphagia  and  the various  strategies  currently  available  to prevent  this  complication.. Introduction
New radiotherapy techniques for head and neck cancer allow
elivery of a curative dose to the tumour volume while sparing
ealthy tissues, thereby decreasing radiation-induced sequelae and
onsequently improving the quality of life of patients in remis-
ion. Healthy tissues included in or adjacent to the irradiated
umour volume, including the skin, mucous membranes, cartilage
nd bone, teeth and salivary glands, constitute the main limitation
o radiotherapy. However, in order to prevent radiation damage
f these anatomical structures, all structures involved in the func-
ion studied must be clearly identiﬁed. For example, the incidence
f xerostomia has been decreased by mainly sparing the parotid
lands or the parotid gland contralateral to the tumour. As swallow-
ng function is much more complex (involving 30 pairs of muscles
nd 6 cranial nerves), the incidence of dysphagia can only be
ecreased after clearly identifying all structures involved in order
o exclude them from radiation ﬁelds. In this review, after recalling
he physiology of swallowing, we will analyse the pathophysiol-
gy of swallowing dysfunction observed after radiotherapy and the
arious options available to prevent these disorders.
. Physiology of swallowingThe process of swallowing is generally deﬁned as all of the mech-
nisms allowing progression of food from the oral cavity to the
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upper oesophageal sphincter. It is associated with protection of the
airways and involves both voluntary and reﬂex mechanisms.
2.1. Preparatory oral phase
The preparatory oral phase consists of preparing food by chew-
ing and impregnating the food with saliva to transform it into a
homogeneous bolus. This phase is both voluntary and involuntary
and involves masticatory muscles, teeth, tongue, salivary glands,
sensory receptors of the oral mucosa and reﬂex arcs, which allow
the tongue to correctly dispose food in the oral cavity so that it
can be ground by the teeth, while at the same time excluding the
tongue from the chewing process. This phase is innervated by cra-
nial nerves V, VII and XII.
2.2. Oral phase
The bolus is then formed on the dorsal surface of the tongue, in
the midline and compressed against the palate by the tongue, then
propelled posteriorly by the base of the tongue, pressing against
the posterior pharyngeal wall while the soft palate is elevated ﬂush
against the posterior pharyngeal wall to prevent the passage of the
bolus into the nasopharynx.
2.3. Pharyngeal and oesophageal phasesThe bolus then advances in the pharynx in the valleculae
between the base of the tongue, the epiglottis and the posterior
pharyngeal wall. The valleculae play a temporary storage role of















































4. Consequences of radiation-induced dysphagia
Depending on the site and initial stage of the tumour, swal-6 S. Servagi-Vernat et al. / European Annals of Otorhin
rotect the laryngeal oriﬁce. The aryepiglottic folds, arytenoid and
rue and false vocal cords form the laryngeal sphincter, which closes
o prevent aspiration. At the same time, the larynx and pharynx rise
nd extend anteriorly by the action of the longitudinal pharyngeal
uscles, while successive contraction of circular constrictor mus-
les allows downward progression of the bolus followed by opening
f the lower oesophageal sphincter, allowing access to the stomach
y peristaltic movements of the oesophageal wall [1].
The ﬁrst two phases are essentially voluntary. Pharyngeal and
esophageal phases are controlled by a reﬂex arc in which the
ensory afferents are carried in cranial nerves V, VII, IX and X (espe-
ially the superior laryngeal nerve and recurrent laryngeal nerve)
nd XII. All these sensory stimuli are integrated in the brainstem
n a centre called the swallowing centre, the main two nuclei of
hich are situated in the nucleus of the solitary tract and in the
ucleus ambiguous of the medulla oblongata. This swallowing cen-
re also receives cortical and subcortical afferents. Efferents from
hese centres travel in cranial nerves V, VII, X and XII to the pharynx
2,3].
When one of these mechanisms is defective, resulting in the
assage of part of the bolus into or below the vestibule (aspira-
ion), sensory receptors of the pharyngeal mucosa are stimulated,
riggering cough via a reﬂex arc involving cranial nerves X, IX, V
nd the brainstem designed to expel the bolus from the larynx [4].
n the absence or in the case of failure of this “rescue mechanism”,
art of the bolus descends below the glottis (inhalation).
. Pathophysiology of radiation-induced dysphagia
Not all of the radiation-induced changes of the structures
nvolved in swallowing have been fully elucidated. Dysphagia can
lso be exacerbated by xerostomia.
.1. Functional changes after radiotherapy
Videoendoscopic analysis of the swallowing process after radio-
herapy reveals [5–7]:
decreased pharyngeal peristalsis and poor synchronization
between pharyngeal contractions, opening of the upper
oesophageal sphincter and closure of the larynx;
decreased or defective posterior inversion of the base of the
tongue towards the posterior pharyngeal wall;
incomplete and/or delayed closure of the larynx with decreased
laryngeal abduction during swallowing;
decreased elevation of the hyoid bone and larynx and decreased
inversion of the epiglottis;
delayed opening of the upper oesophageal sphincter.
All of these abnormalities are responsible for dysphagia, a risk
f aspiration and/or persistence of residues of the bolus in the
ropharynx, valleculae and hypopharynx at the end of the swal-
owing phase, which may  then be subsequently inhaled. The cough
eﬂex is also often deﬁcient or even absent after radiotherapy [8].
.2. Histological changes after radiotherapy
Radiation-induced lesions can be schematically classiﬁed into
wo main pathophysiological processes affecting all tissues:
nﬂammation (and the resulting oedema) and ﬁbrosis [9,10].
icrovascular changes, atrophy of muscle ﬁbres and vessels, and
ollagen deposits are also observed..2.1. Mucous membranes
Late radiation-induced mucositis comprises loss of colour, thin-
ing, rigidity of the mucosa and induration of the subcutaneousngology, Head and Neck diseases 132 (2015) 25–29
tissues and can be complicated by ulceration and necrosis. These
disorders are due to ischaemia secondary to ﬁbrosis and occlusion
of small vessels. These effects are progressive and irreversible and
may  be observed between 6 months and 5 years after radiotherapy.
3.2.2. Muscles
In a prospective study on 26 patients, CT scans were acquired
before and after radiotherapy to identify the structures damaged by
radiotherapy. Pharyngeal constrictor muscles, with a mean thick-
ness of 2 mm before radiotherapy, were thicker after radiotherapy,
reaching a mean thickness of 7 mm [6]. In another study on 12
patients, Popovtzer et al. [11] studied MRI  signal changes on T1-
and T2-weighted sequences as well as variations of the thickness
of pharyngeal constrictor muscles 3 months after radiotherapy. The
mean thickness of pharyngeal constrictor muscles increased from
2.9 mm before radiotherapy to 5.4 mm after radiotherapy. These
authors also compared the thickness of the pharyngeal constric-
tor muscles with that measured on sternocleidomastoid muscles
(SCM). They observed a reduction of the T1 signal after radiother-
apy in both the pharyngeal constrictor muscles and the SCM, while
the T2 signal was markedly increased after radiotherapy in the pha-
ryngeal constrictor muscles, but only very moderately increased in
the SCM. This signal increase was dose-dependent for pharyngeal
constrictor muscles, but not for the SCM. On average, the thickness
of the pharyngeal constrictor muscles was doubled after radio-
therapy, while the thickness of SCM tended to decrease. These
ﬁndings suggest that pharyngeal constrictor muscles are more sus-
ceptible to radiation-induced inﬂammation than the SCM, as the
high-intensity T2 signal reﬂects the presence of oedema and inﬂam-
mation. This inﬂammation of pharyngeal constrictors appears to be
secondary to acute inﬂammation of the pharyngeal mucosa cov-
ering these muscles, suggesting that inﬂammation is propagated
contiguously to the underlying constrictor muscles.
Other muscles may  also be involved, such as the pterygoid
and masseter muscles, associated with temporo-mandibular joint
lesions due to thinning of cartilage and rarefaction of synovial ﬂuid,
responsible for radiation-induced trismus [12]. Cricopharyngeus
muscle dysfunction has also been reported [13].
3.2.3. Nerves
It is difﬁcult to determine whether pharyngeal constrictor mus-
cle dysfunction is exclusively due to muscle lesions, or whether
nerve lesions may  also be involved. Fajardo et al. [14] did not
demonstrate any morphological lesions of the ganglia innervating
the oesophagus and pharynx after radiotherapy. However, possi-
ble nerve dysfunction with no morphological changes cannot be
excluded. The terminal innervation of the pharynx is essentially
ensured by the pharyngeal plexus, innervated by cranial nerves V,
VII, IX and X situated in the connective tissue sheath surrounding
the pharyngeal muscles, which terminal ﬁbres pierce the muscle
layer to terminate in the mucosa and submucosa [15]. Mucosal
changes can damage the terminal afferent and efferent nerve ﬁbres
present in the mucosa, responsible for sensory and motor disorders,
for example denervation of one half of the tongue by late ﬁbrotic
stenosis [stenosis or damage?] of the hypoglossal nerve [16].lowing disorders may  already be present prior to any treatment,
making it difﬁcult to assess dysphagia due exclusively to radio-
therapy. In the meta-analysis by Machtay et al., 43% of patients in
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.1. Consequences on quality of life
Radiation-induced dysphagia is responsible for a change in the
ype of diet and prolongation of meal times, which participate
n anorexia and post-treatment latent malnutrition. As eating is
n essential social activity, eating disorders can result in isolation
f the patient, constituting an additional factor of impaired qual-
ty of life [18,19]. In a study based on 72 patients with stage III
nd IV oropharyngeal cancer treated by concurrent radiotherapy
nd chemotherapy using an intensity-modulated radiation therapy
echnique, quality of life evaluated at 6 and 12 months after treat-
ent was closely correlated with dysphagia evaluated by CTCAE
ersion 2. Other toxicities, such as xerostomia or radiation-induced
brosis had a lesser impact on quality of life [20]. The use of a
eeding tube justiﬁed by the patient’s nutritional status also alters
uality of life [21,22]. In a study on 570 patients, Terrell et al.
21] investigated the clinical predictors of quality of life of patients
valuated by SF36 and HNQoL, such as tumour site, tumour stage,
resence of a tracheotomy, presence of a feeding tube, laryngec-
omy, lymph node dissection, radiotherapy, chemotherapy, other
omorbidities and time since diagnosis. The presence of a feeding
ube was the factor with the greatest impact on quality of life with
 difference of up to –30 compared to a control population. In con-
rast, long-term gastrostomy had a lesser impact on the patient’s
uality of life [22].
.2. Aspiration pneumonia
The estimated frequency of aspiration after chemoradiotherapy
s between 40 and 80% in recent studies evaluating swallowing
isorders by videoendoscopy [5,23,24]. Aspiration can lead to aspi-
ation pneumonia, which is a leading cause of morbidity and even
ortality in these patients. In a study on 22 patients evaluated
y videoﬂuoroscopy before, at the end, and 6 to 12 months after
adiotherapy, aspirations were reported by 14% of patients before,
2% at the end, and 65% between 6 and 12 months after radio-
herapy. Six patients (28%) developed aspiration pneumonia during
ollow-up that was the cause of death in two patients (10%). Five of
hese 6 cases of aspiration pneumonia were associated with docu-
ented aspirations on endoscopy [5]. Placement of a feeding tube
ecreased but did not completely eliminate the risk of aspiration
nd aspiration pneumonia [25].
. How to reduce the risk of radiation-induced dysphagia?
.1. The use of new external beam radiotherapy techniques
The development of multileaf collimators (MLC) allowed
eplacement of lead shields for conformation of static beams.
Step and shoot” MLC  techniques or dynamic or sliding window
LC  techniques now allow the use of beams of variable intensity.
ntensity-modulated radiation therapy (IMRT) uses combinations
f several beams each with a controlled inhomogeneity to provide
 dose distribution perfectly adapted to the target volume while
paring organs at risk. Dynamic arc therapy is a new IMRT technique
hat delivers a rotational volumetric modulated radiotherapy that
iffers from conventional IMRT by varying the speed of rotation of
he accelerator gantry, collimator leaf speed and ﬂuence (dose rate).
wo machines are currently marketed: RapidArc® (Varian Medi-
al Systems) and VMAT® (Elekta). Dynamic arc therapy also allows
ore homogeneous tumour coverage and more effective sparing
f healthy tissues.
The use of IMRT, followed by dynamic arc therapy has
ecreased the incidence of xerostomia [26,27]. A third machine
an also be used to deliver intensity-modulated radiation therapy:gology, Head and Neck diseases 132 (2015) 25–29 27
Tomotherapy® (Accuray) that delivers intensity-modulated radi-
ation therapy with a spiral delivery pattern. Regardless of the
machine used for dose delivery, prescription by beam optimization
is determined by calculation algorithms (TPS, Treatment Planning
System) in which the volumes of interest (tumour target volumes
and organs at risk), dose constraints and priorities for each volume
are entered. The TPS then optimizes the intensity proﬁle of each
beam to comply with these parameters.
5.2. Dose constraints used in the TPS
Many studies have investigated the correlation between the
dose delivered to organs involved in swallowing and reduction of
swallowing function after radiotherapy [1,9,23,28–36]. The results
of these various studies are fairly concordant, showing a strong
correlation between the dose received by the pharyngeal constric-
tor muscles, larynx and oesophagus and swallowing disorders. The
most predictive dosimetric indices for the larynx are the mean dose
(Dmean) [1,28,31,33–35,37] the volume receiving a dose of 50 Gy
(V50) [28,31,37] and the volume receiving a dose of 60 Gy  (V60) [34].
The most predictive dosimetric indices for the pharyngeal constric-
tor muscles are Dmean [1,9,28,30,31,33,36,37], V50 [37], V55 [23],
V60 [38], V65 [1,5,28,34,38] and V70 [39]. Oesophageal dose con-
straints have been described by many authors as a major risk factor
for swallowing disorders, but these various studies did not deﬁne
the oesophageal volume in the same way [28,30,31,35,38]. Some
authors considered all of the cervical oesophagus [31,35], while
others only considered the cricopharyngeus muscle [30,33,38] or
the upper oesophageal sphincter (deﬁned as the ﬁrst centimetre of
the oesophagus below the cricopharyngeus muscle) [33].
Compliance with these maximum dose guidelines for organs
involved in swallowing therefore decreases the risk of dysphagia
depending on the tumour site, while ensuring optimal delivery to
the tumour target volume.
5.3. Assessment to prevent the consequences of radiation injuries
Personalized dietetic advice and medium-term follow-up
should be proposed during exclusive radiotherapy or chemoradio-
therapy. Feeding gastrostomy is recommended in malnourished
patients and can also be proposed in non-malnourished patients
receiving oropharyngeal radiotherapy. Oral nutritional supple-
ments can be considered in non-malnourished patients not
receiving oropharyngeal radiotherapy, while a nasogastric tube is
recommended if oral intake is insufﬁcient [40].
It is important to assess dysphagia during follow-up of patients
in remission in order to implement appropriate dietary measures
and rehabilitation depending on the severity of dysphagia:
• dysphagia can be quantiﬁed on the basis of clinical interview,
possibly by using a rating scale: CTCAE v4.0 [41], RTOG/EORTC,
Performance Status Scale for Head and Neck cancer (PSS-H&N)
[42];
• weight loss during treatment is an easily measurable objective
parameter. However, a patient’s food intake may be decreased
for reasons other than dysphagia (especially anorexia, dysgeusia
and mouth pain related to mucositis);
• videoﬂuoroscopy: the patient is required to swallow barium-
labelled elements of different volumes and densities that are then
visible during videoﬂuoroscopy. Videoﬂuoroscopy is entirely
recorded and each phase of swallowing (oral, pharyngeal and
oesophageal) is analysed and timed. A residual bolus persist-
ing after the end of swallowing is investigated. Aspiration is
deﬁned as part of the bolus entering the vestibule. Inhalation is
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patient’s reaction during aspiration is also analysed: cough with
ejection of the bolus, insufﬁcient cough not allowing ejection
of all of the bolus or absence of cough reﬂex [18,43–45]. Data
derived from this examination can be combined with clinical data
to constitute a score, the Swallowing Performance Scale, which
combines radiological results with the type of diet, the presence
of aspiration on clinical examination, and the corrective measures
taken (food supplements, feeding tube). This examination can
also be combined with manometry, which measures pressures
in the pharynx, upper oesophageal sphincter and the oesopha-
gus during swallowing [13]. Concomitant videoﬂuoroscopy and
manometry can be used to correlate movements of anatomical
structures with the intraluminal pressure of the structure;
endoscopy: evaluation of swallowing by transnasal endoscopy
suspended just posteriorly to the soft palate allows evaluation
during phonation, spontaneous deglutition and voluntary swal-
lowing of substances of various viscosities. The sensitivity of the
pharynx is evaluated by pressure of the endoscope against the
mucosa. The valleculae and pyriform sinus are also examined for
the presence of residues of the bolus at the end of the swallow-
ing. This examination can be used to demonstrate the presence
of aspiration and the patient’s reaction to aspiration, as well as
the presence of stenosis [13,46,47].
.4. Functional rehabilitation
An adapted diet and functional rehabilitation can be proposed
ccording to the degree of dysphagia. Many swallowing exercises
ave been described for patients treated by radiotherapy [48–51]. A
andomized trial was conducted on 58 patients treated by concur-
ent chemoradiotherapy divided into 3 arms: a standard arm with
sual care to prevent dysphagia, an arm with gentle rehabilitation
nd appropriate diet and an intensive rehabilitation arm, which
emonstrated the impact of swallowing exercises on the muscles
nvolved in swallowing. Genioglossus, hyoglossus and mylohyoid
uscles demonstrated less structural deterioration on MRI  (mus-
le thickness and T2 signal) in the intensive rehabilitation arm
t 6 months. Similarly, better quality swallowing, salivation and
outh opening were observed in the intensive rehabilitation arm
52].
. Conclusion
Due to the complexity of the anatomical structures involved
n head and neck cancer and/or adjacent healthy tissues (salivary
lands, structures involved in swallowing disorders), radiotherapy
or head and neck cancer remains a challenge for radiotherapists.
ew radiotherapy techniques allow a reduction of certain late
oxicities without compromising tumour sterilization. The system-
tic use of dose constraints on structures involved in swallowing,
ccording to the tumour site, will help to decrease the incidence of
ysphagia. A multidisciplinary approach to these patients ensures
ptimal management allowing prevention of these disorders and
upportive measures such as functional rehabilitation that is still
nsufﬁciently proposed.
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